These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25807948)

  • 1. Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy.
    Callaly E; Walder K; Morris G; Maes M; Debnath M; Berk M
    Mini Rev Med Chem; 2015; 15(5):355-65. PubMed ID: 25807948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of mitochondrial dysfunction in bipolar disorder.
    Kato T
    Drug News Perspect; 2006 Dec; 19(10):597-602. PubMed ID: 17299601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of newer anticonvulsants.
    White HS
    J Clin Psychiatry; 2003; 64 Suppl 8():5-8. PubMed ID: 12892535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current understanding of bipolar disorder: Toward integration of biological basis and treatment strategies.
    Kato T
    Psychiatry Clin Neurosci; 2019 Sep; 73(9):526-540. PubMed ID: 31021488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the bipolar spectrum and treating bipolar II disorder.
    Vieta E
    J Clin Psychiatry; 2008 Apr; 69(4):e12. PubMed ID: 18507485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia.
    Clay HB; Sillivan S; Konradi C
    Int J Dev Neurosci; 2011 May; 29(3):311-24. PubMed ID: 20833242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
    Hamrin V; McDonnell MA; Moffett J; Durso S
    Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic treatment of bipolar disorder in children and adolescents.
    Goldstein BI; Sassi R; Diler RS
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):911-39. PubMed ID: 23040907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Dysfunctions in Bipolar Disorder: Effect of the Disease and Pharmacotherapy.
    Cikankova T; Sigitova E; Zverova M; Fisar Z; Raboch J; Hroudova J
    CNS Neurol Disord Drug Targets; 2017; 16(2):176-186. PubMed ID: 27978794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder.
    de Sousa RT; Machado-Vieira R; Zarate CA; Manji HK
    Expert Opin Ther Targets; 2014 Oct; 18(10):1131-47. PubMed ID: 25056514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Hamrin V; Pachler M
    J Child Adolesc Psychiatr Nurs; 2007 Feb; 20(1):40-58. PubMed ID: 17284237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development.
    Nierenberg AA; Kansky C; Brennan BP; Shelton RC; Perlis R; Iosifescu DV
    Aust N Z J Psychiatry; 2013 Jan; 47(1):26-42. PubMed ID: 22711881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Agents for Bipolar Disorder.
    Pereira C; Chavarria V; Vian J; Ashton MM; Berk M; Marx W; Dean OM
    Int J Neuropsychopharmacol; 2018 Jun; 21(6):550-569. PubMed ID: 29596661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications.
    Scaini G; Rezin GT; Carvalho AF; Streck EL; Berk M; Quevedo J
    Neurosci Biobehav Rev; 2016 Sep; 68():694-713. PubMed ID: 27377693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects of mitochondrial electron transport chain in bipolar disorder: implications for mood-stabilizing treatment.
    Wang JF
    Can J Psychiatry; 2007 Dec; 52(12):753-62. PubMed ID: 18186175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming the current approach in bipolar disorder research: towards DSM-V and beyond.
    Vieta E
    J Psychopharmacol; 2008 Jun; 22(4):406-7; discussion 408. PubMed ID: 18635719
    [No Abstract]   [Full Text] [Related]  

  • 17. Bipolar Disorder.
    Miller TH
    Prim Care; 2016 Jun; 43(2):269-84. PubMed ID: 27262007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
    Simon NM; Otto MW; Weiss RD; Bauer MS; Miyahara S; Wisniewski SR; Thase ME; Kogan J; Frank E; Nierenberg AA; Calabrese JR; Sachs GS; Pollack MH;
    J Clin Psychopharmacol; 2004 Oct; 24(5):512-20. PubMed ID: 15349007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder.
    Scaini G; Andrews T; Lima CNC; Benevenuto D; Streck EL; Quevedo J
    Mitochondrion; 2021 Mar; 57():23-36. PubMed ID: 33340709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The changing drug therapy of bipolar disorder].
    Leinonen E
    Duodecim; 1999; 115(17):1911-7. PubMed ID: 11941660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.